logo

Research

Help: To find Illnesses or Conditions associated with a Herbal Remedy. Select a letter from A - Z of Herbal Remedies. Or Scroll lists. Or Use Search.

Nettle Remedies


Nettle - Herbal Research
A WHO Organizational resource: Nettle Research - FULL REPORT


Medicinal uses supported by clinical data
 
Symptomatic treatment of lower urinary tract disorders (nocturia, polyuria, urinary retention) resulting from BPH stages I and II, as defined by Alken, in cases where diagnosis of prostate cancer is negative (22-35).
 
Uses described in pharmacopoeias and traditional systems of medicine
 
As a diuretic and for the treatment of rheumatism and sciatica (6).
 
Uses described in folk medicine, not supported by experimental or clinical data
 
Treatment of asthma, coughs, dandruff, diabetes, diarrhoea, eczema, fever, gout, haemorrhoids, nose bleeds, scurvy, snakebites and tuberculosis (5, 6). The plant has also been used to stop uterine bleeding after childbirth, increase lactation and promote hair growth, and as a vermifuge (5, 6).

References:

5. Farnsworth NR, ed. NAPRALERT database. Chicago, University of Illinois at Chicago, IL, February 9, 1998 production (an online database available directly through the University of Illinois at Chicago or through the Scientific and Technical Network [STN] of Chemical Abstracts Services).
 
6. Patten G. Urtica. Australian Journal of Medical Herbalism, 1993, 5:5-13.
 
22. Bauer HW et al. Endokrine Parameter während der Behandlung der benignen Prostatahyperplasie mit ERU. In: Bauer HW, ed. Benigne Prostatahyperplasie II, klinische und experimentelle Urologie 19. Munich, Zuckschwerdt, 1988.
 
23. Belaiche P, Lievoux O. Clinical studies on the palliative treatment of prostatic adenoma with extract of Urtica root. Phytotherapy Research, 1991, 5:267-269.
 
24. Dathe G, Schmid H. Phytotherapie der benignen Prostatahyperplasie (BPH). Doppelblindstudie mit Extraktum Radicis Urticae (ERU). Urologie [B], 1987, 27:223-226.
 
25. Djulepa J. Zweijährige Erfahrung in der Therapie des Prosta-Syndroms. Ärztliche Praxis, 1982, 34:2199-2202.
 
26. Feiber H. Sonographische Verlaufsbeobachtungen zum Einfluss der medikamentösen Therapie der benignen Prostatahyperplasie (BPH). In: Bauer HW, ed. Benigne Prostatahyperplasie II, klinische und experimentelle Urologie 19. Munich, Zuckschwerdt, 1988.
 
27. Fisher M, Wilbert D. Wirkprüfung eines Phytopharmakons zur Behandlung der benignen Prostatahyperplasie (BPH). In: Rutishauser G, ed. Benigne Prostatahyperplasie III, klinische und experimentelle Urologie 22. Munich, Zuckschwerdt, 1992:79-83.
 
28. Friesen A. Statistische Analyse einer Multizenter-Langzeitstudie mit ERU. In: Bauer HW, ed. Benigne Prostatahyperplasie II, klinische und experimentelle Urologie 19. Munich, Zuckschwerdt, 1988:121-130.
 
29. Goetz P. Die Behandlung der benignen Prostatahyperplasie mit Brennesselwurzeln. Zeitschrift für Phytotherapie, 1989, 10:175-178.
 
30. Sonnenschein R. Untersuchung der Wirksamkeit eines prostatotropen Phytotherapeutikums (Urtica plus) bei benigner Prostatahyperplasie und Prostatitis - eine prospektive multizentrische Studie. Urologie [B], 1987, 27:232-237.
 
31. Stahl HP. Die Therapie prostatischer Nykturie. Zeitschrift für Allgemeine Medizin, 1984, 60:128-132.
 
32. Tosch U et al. Medikamentöse Behandlung der benignen Prostatahyperplasie. Euromed, 1983, 6:1-3.
 
33. Vahlensieck W. Konservative Behandlung der benignen Prostatahyperplasie. Therapiewoche Schweiz, 1986, 2:619-624.
 
34. Vandierendounck EJ, Burkhardt P. Extractum radicis urticae bei Fibromyoadenom der Prostata mit nächtlicher Pollakisurie. Therapiewoche Schweiz, 1986, 2:892-895.
 
35. Vontobel HP et al. Ergebnisse einer Doppelblindstudie über die Wirksamkeit von ERU-Kapseln in der konservativen Behandlung der benignen Prostatahyperplasie. Urologie [A], 1985, 24:49-51.


Health Issues

UK-based trade group the Health Food Manufacturers Association (HFMA) has written a formal letter of complaint to the BBC about a controversial BBC2 Horizon programme about the food supplements industry.

VIEW MORE

Consumers are demanding BPA-free products, but the alternatives are no safer. Despite this alarming data, nearly 81% of Americans have detectable levels of BPS in their urine.

VIEW MORE

Widely promoted as a ‘safe’ and ‘healthy’ alternative way to quit smoking, the adoption of vaping has grown exponentially in recent years.

VIEW MORE